Oncotelic Therapeutics (OTLC) Return on Assets [ROA] (2011 - 2026)
Oncotelic Therapeutics' Return on Assets [ROA] came in at 63.40% for Q2 2026, up 79.07 percentage points from -15.67% a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Oncotelic Therapeutics' Return on Assets [ROA] was 118.65%, up 135.51 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of +160.77 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -16.86% in FY2024 (+7.96 pp), -24.82% in FY2023 (-40.48 pp), 15.66% in FY2022 (+60.15 pp) and -44.49% in FY2021 (-2.37 pp).
- The five-year range for quarterly Return on Assets [ROA] is -53.42% (Q1 2022) to 118.23% (Q4 2025).
- Year-over-year, Return on Assets [ROA] increased in six of the last seven quarters, with an average year-over-year change of +36.97 percentage points.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2025 (a gain of 136.11 percentage points), and the weakest in Q2 2023 (a drop of 63.57 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.00% |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - | 62.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.40% |
| Dec 31, 2025 | 118.23% |
| Sep 30, 2025 | -7.01% |
| Jun 30, 2025 | -15.67% |
| Mar 31, 2025 | -17.50% |
| Dec 31, 2024 | -17.88% |
| Sep 30, 2024 | -17.34% |
| Jun 30, 2024 | -5.02% |
| Mar 31, 2024 | -26.92% |
| Dec 31, 2023 | -27.30% |
| Sep 30, 2023 | -42.45% |
| Jun 30, 2023 | -41.36% |
| Mar 31, 2023 | 25.39% |
| Dec 31, 2022 | 12.25% |
| Sep 30, 2022 | 19.97% |
| Jun 30, 2022 | 22.21% |
| Mar 31, 2022 | -53.42% |
| Dec 31, 2021 | -44.94% |
| Sep 30, 2021 | -53.11% |
| Jun 30, 2021 | -52.78% |
API Access
Oncotelic Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();